Investigators

Anaveon works closely with Health Care Professionals and Academic Investigators around the world either via Investigator Initiated Studies or Research Collaborations.

We are interested in and support:

Research collaborations or material transfer agreements (MTA)

Characterization of cytokines in the tumor microenvironment
Cell therapies
Preclinical proof of concept (PoC) in combination with other compounds

Investigator-initiated studies (IIS)

Cell therapy settings including tumor infiltration lymphocytes (TIL) therapy, NK cell therapy including NK cell engagers
Immunization and cancer vaccine settings in combination with targeted therapies

If you wish to learn more about collaborating with Anaveon, please contact us:

Corporate Positioning & Design, Concept, Webdesign & Code:
Schlatter corporate GmbH
Davidstrasse 45
CH-9000 St.Gallen
schlattercorporate.com